Revenue: The sum of all revenue fields included for a company's operating activities.
REGENXBIO Inc. (RGNX) had Revenue of $21.36M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$21.36M |
$-70.87M |
|
$5.21M |
|
$16.15M |
|
$84.64M |
|
$-63.28M |
|
$-7.59M |
|
$-70.87M |
|
$-70.87M |
|
$-70.87M |
|
$-70.87M |
|
$-70.87M |
|
$-70.87M |
|
$-63.28M |
|
$-60.73M |
|
51.48M |
|
51.48M |
|
$-1.38 |
|
$-1.38 |
|
| Balance Sheet Financials | |
$373.75M |
|
$111.02M |
|
$207.28M |
|
$581.03M |
|
$119.54M |
|
-- |
|
$247.81M |
|
$367.35M |
|
$213.68M |
|
$213.68M |
|
$213.68M |
|
50.39M |
|
| Cash Flow Statement Financials | |
$-15.71M |
|
$-95.69M |
|
$133.44M |
|
$59.56M |
|
$81.59M |
|
$22.03M |
|
$17.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
75.61% |
|
-296.26% |
|
-296.26% |
|
-- |
|
-331.81% |
|
-331.81% |
|
$-17.13M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.06 |
|
85.11 |
|
-33.17% |
|
-33.17% |
|
-12.20% |
|
-33.17% |
|
$4.24 |
|
$-0.33 |
|
$-0.31 |
|